| Heterogeneous patterns of brain atrophy in Alzheimer's disease K Poulakis, JB Pereira, P Mecocci, B Vellas, M Tsolaki, I Kłoszewska, ... Neurobiology of aging 65, 98-108, 2018 | 136 | 2018 |
| Brain myoinositol as a potential marker of amyloid-related pathology: A longitudinal study O Voevodskaya, K Poulakis, P Sundgren, D van Westen, S Palmqvist, ... Neurology 92 (5), e395-e405, 2019 | 41 | 2019 |
| Multi-cohort and longitudinal Bayesian clustering study of stage and subtype in Alzheimer’s disease K Poulakis, JB Pereira, J Muehlboeck, LO Wahlund, Ö Smedby, G Volpe, ... Nature Communications 13 (1), 1-15, 2022 | 29 | 2022 |
| Comparison of subtyping methods for neuroimaging studies in Alzheimer’s disease: a call for harmonization R Mohanty, G Mårtensson, K Poulakis, JS Muehlboeck, ... Brain communications 2 (2), fcaa192, 2020 | 29 | 2020 |
| [18 F] THK5317 imaging as a tool for predicting prospective cognitive decline in Alzheimer’s disease K Chiotis, I Savitcheva, K Poulakis, L Saint-Aubert, A Wall, G Antoni, ... Molecular Psychiatry, 1-13, 2020 | 17* | 2020 |
| Fully bayesian longitudinal unsupervised learning for the assessment and visualization of AD heterogeneity and progression K Poulakis, D Ferreira, JB Pereira, Ö Smedby, P Vemuri, E Westman Aging (Albany NY) 12 (13), 12622, 2020 | 16 | 2020 |
| Longitudinal deterioration of white-matter integrity: heterogeneity in the ageing population K Poulakis, RI Reid, SA Przybelski, DS Knopman, J Graff-Radford, ... Brain communications 3 (1), fcaa238, 2021 | 14 | 2021 |
| Unraveling Parkinson's disease heterogeneity using subtypes based on multimodal data F Albrecht, K Poulakis, M Freidle, H Johansson, U Ekman, G Volpe, ... Parkinsonism & Related Disorders, 2022 | 9 | 2022 |
| Cerebrospinal Fluid Biomarkers, Brain Structural and Cognitive Performances Between Normotensive and Hypertensive Controlled, Uncontrolled and Untreated 70-Year-Old Adults A Badji, JB Pereira, S Shams, J Skoog, A Marseglia, K Poulakis, L Rydén, ... Frontiers in aging neuroscience 13, 2021 | 8 | 2021 |
| Brain Atrophy Subtypes and the ATN Classification Scheme in Alzheimer’s Disease N Cedres, U Ekman, K Poulakis, S Shams, L Cavallin, S Muehlboeck, ... Neurodegenerative Diseases, 1-12, 2021 | 6 | 2021 |
| MRI data-driven clustering reveals different subtypes of Dementia with Lewy bodies A Inguanzo, K Poulakis, R Mohanty, CG Schwarz, SA Przybelski, ... npj Parkinson's Disease 9 (1), 5, 2023 | 5 | 2023 |
| Clustering and disease subtyping in Neuroscience, toward better methodological adaptations K Poulakis, E Westman Frontiers in Computational Neuroscience 17, 1243092, 2023 | 3 | 2023 |
| Demographic and Clinical Characteristics of Individuals with Mild Cognitive Impairment Related to Grade of Alcohol Consumption T Tsevis, E Westman, K Poulakis, O Lindberg, A Badji, D Religa, ... Dementia and geriatric cognitive disorders, 1-7, 2021 | 3 | 2021 |
| MRI subtypes in Parkinson’s disease: Unraveling differences across diverse populations and clustering approaches A Inguanzo, R Mohanty, K Poulakis, D Ferreira, B Segura, F Albrecht, ... | | 2024 |
| Alzheimer's disease heterogeneity assessment using high dimensional clustering techniques K Poulakis | | 2016 |
| Linear regression models in predicting acute myocardial infarction progression from serum levels of TNI, CRP and AST. K Poulakis, M Chouzouris, A Konstantopoulos, K Daskalopoulou, ... Archives of Hellenic Medicine/Arheia Ellinikis Iatrikis 32 (1), 2015 | | 2015 |
